Medical News

RSS

Plastic surgery on the rise among Americans

13.8 million plastic surgery procedures were performed in 2011, a 5% increase on the year before. The authors added that by the end of 2011, the number of total plastic surgeries had grown for 24 consecutive months. These figures include both minimally-invasive and surgical procedures. The ASPS informs that 5.5 additional reconstructive procedures were carried out in 2011, also a 5% increase on the previous year.

13 Feb 2012

High calories associated with memory loss in elderly: Study

Overeating may lead to a higher risk of memory loss say researchers. A new study found that elderly who consumed more than 2,143 calories a day had more than double the risk of a type of memory loss called mild cognitive impairment (MCI) compared to those who ate fewer than 1,500 calories a day. The study appeared Sunday by the American Academy of Neurology on its website (aan.com).

13 Feb 2012

Diffusion opens enrollment for TSC clinical trial for newly diagnosed primary brain cancer

Diffusion Pharmaceuticals LLC announced today that it has opened for enrollment a clinical trial testing the company's lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM.

13 Feb 2012

Third patient dosed in Phase 1/2 SMD trial using RPE cells derived from hESCs

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today the dosing of third patient in its Phase 1/2 trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

13 Feb 2012

InComm announces acquisition of Medagate

InComm, a leading prepaid product and transaction services company, announced today that it has acquired Medagate Corporation, the company that powers OTCNetwork, the only national closed loop over-the-counter (OTC) healthcare benefits payments platform.

13 Feb 2012

Tenofovir associated with significant risk of kidney damage and chronic kidney disease

Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco (UCSF).

13 Feb 2012

Cardium to raise $5.0 million in registered direct offering

Cardium Therapeutics today announced that it has entered into definitive agreements with three institutional and accredited investors to sell an aggregate of 17,857,143 shares of its common stock in a registered direct offering for gross proceeds of approximately $5.0 million, before deducting placement agent's fees and estimated offering expenses.

13 Feb 2012

Merck's ZIOPTAN for reducing elevated IOP receives FDA approval

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has approved ZIOPTANTM (tafluprost ophthalmic solution) 0.0015%, the first preservative-free prostaglandin analog ophthalmic solution.

13 Feb 2012

Forbes examines how mobile phones are improving access to care in developing world

Mobile phones are improving access to health care in the developing world, according to the series "The Future of mHealth" by Mobiledia, a Forbes contributor.

13 Feb 2012

Bode announces acquisition of Chromosomal Laboratories

Bode Technology, a leading provider of forensic DNA services, announced today the acquisition of Chromosomal Laboratories, Inc., a leading provider of DNA testing for immigration and private paternity.

13 Feb 2012

Lawmakers facing showdown on payroll tax, Medicare bill

A weekend of talks between the two top tax writers in Congress failed to bridge gaping partisan differences over the payroll tax cut package, increasing the odds of another Washington showdown ahead of an end-of-the-month deadline.

13 Feb 2012

Bristol-Myers completes tender offer for Inhibitex

Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company for all of the outstanding shares of common stock of Inhibitex, Inc. at a purchase price of $26.00 per share.

13 Feb 2012

Premier healthcare alliance awards new agreements for feeding pumps, sets, tubes and devices

The Premier healthcare alliance today announced new agreements for feeding pumps, sets, tubes and devices have been awarded to Abbott Nutrition of Columbus, Ohio; CORPAK MedSystems Inc. of Buffalo Grove, Ill.; Covidien of Mansfield, Mass.; Kimberly-Clark Global Sales LLC of Roswell, Ga.; and Moog Inc. Medical Devices Group of Salt Lake City, Utah.

13 Feb 2012

Discovery of novel rearrangements and fusions supports role for NGS in treatment of cancer

Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer gene analysis to routine clinical care, and Dana-Farber Cancer Institute today announced the Nature Medicine publication of results from their collaborative next-generation sequencing (NGS) study to assay cancer-relevant genes in 24 non-small cell lung cancer (NSCLC) and 40 colorectal cancer (CRC) cases.

13 Feb 2012

DARPA awards fourth milestone payment of $3.56M to Medicago

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.

13 Feb 2012

Most pharmas concerned over ability to meet EMA EVMPD deadline

Polling conducted by Virtify, Inc. revealed that most pharmaceutical companies are concerned about their ability to comply with the requirement to submit additional pharmacovigilance data to the EMA EudraVigilance Medicinal Product Dictionary (EVMPD) in advance of the July 2, 2012 deadline.

13 Feb 2012

Intervention programs can help teen girls achieve long-term success in managing weight

Teenage girls gained less weight, improved their body image, ate less fast food, and had more family meals after participating in a 6- month program that involved weekly peer meetings, consultations with primary care providers and separate meetings for parents. Those results from a study published online today in the journal Pediatrics.

13 Feb 2012

EU-funded 4DCellFate project to kick off today

Today European scientists are meeting to kick off the 4DCellFate project, funded by the European Commission under the FP7 program.

13 Feb 2012

Progesterone vaginal gel 8% NDA transferred to Watson

Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has transferred the new drug application for progesterone vaginal gel 8% for use in the reduction of risk of preterm birth in women with a singleton gestation and a short uterine cervical length in the mid-trimester of pregnancy (NDA 22-139) to Watson.

13 Feb 2012

Some Senate Democrats split from White House on contraception rule

The White House on Thursday faced mounting pressure from Senate Democrats to amend its requirements that religious employers include contraceptives in their health insurance plans, as Republicans tried to force votes on the issue.

13 Feb 2012